Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Boehringer Ingelheim
Colorcon
US Army
Deloitte

Generated: May 26, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,553,863

« Back to Dashboard

Which drugs does patent 7,553,863 protect, and when does it expire?

Patent 7,553,863 protects ANTIZOL and is included in one NDA.

This patent has nine patent family members in eight countries.

Summary for Patent: 7,553,863
Title:Ultrapure 4-methylpyrazole
Abstract:Disclosed is an ultrapure 4-methylpyrazole containing less than 0.1% pyrazole and containing less than 10 ppm each of hydrazine and nitrobenzaldehyde. The ultrapure 4-methylpyrazole is prepared by a novel process so that less than 0.01% of ethylvinyl ether is present.
Inventor(s): Reardan; Dayton T. (Shorewood, MN), Combe; Michel D. (Fox Point, WI)
Assignee: Paladin Labs (Barbados) Inc. (Barbados, BB)
Application Number:11/279,708
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,553,863
Patent Claim Types:
see list of patent claims
Formulation; Compound; Process; Composition;

Drugs Protected by US Patent 7,553,863

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Par Pharm Inc ANTIZOL fomepizole INJECTABLE;INJECTION 020696-001 Dec 4, 1997 AP RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Citi
Healthtrust
Harvard Business School
Julphar
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.